DNA repair and cancer: lessons from mutant mouse models

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• DNA damage accumulation, due to compromised repair pathways like nucleotide excision repair (NER), can lead to mutations and cancer.
• Defects in DNA damage response pathways, such as p53, are implicated in carcinogenesis.
• Human cancer predisposition syndromes highlight the clinical significance of inherited DNA repair defects.

Purpose of the Study:

• To review in vivo experimental data on the protective role of DNA repair machinery in chemical carcinogenesis.
• To focus on the function of DNA repair genes MGMT, XPA, and p53 in preventing cancer.
• To support clinical observations with evidence from animal models.

Main Methods:

• Review of in vivo experimental data from genetically modified mouse models.
• Focus on mouse models overexpressing MGMT, deficient in XPA, and null for p53.
• Analysis of spontaneous and carcinogen-induced tumorigenesis in these models.

Main Results:

• Mice overexpressing MGMT showed resistance to nitrosamine-induced liver cancer and reduced spontaneous tumors.
• XPA mutant mice exhibited increased susceptibility to spontaneous and induced tumors.
• Loss of p53 in XPA mutant mice accelerated carcinogenesis, and p53 null mice were prone to brain tumors.

Conclusions:

• The DNA repair system plays a vital role in protecting against cancer.
• Experimental data from MGMT, XPA, and p53 mouse models strongly support the tumor-suppressive function of DNA repair.
• These models provide crucial in vivo evidence for the clinical observations of DNA repair defects and cancer predisposition.